XS
ELV icon

XR Securities’s Elevance Health ELV Stock Holding History

XR Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,200
Closed -$1.01M – 407
2023
Q1 		$1.01M Buy
2,200
+600
+38% +$286K 0.03% 184
2022
Q4 		$821K Buy
+1,600
New +$812K 0.08% 190
2020
Q1 		– Sell
-9,200
Closed -$356K – 229
2019
Q4 		$356K Buy
+9,200
New +$2.53M 0.05% 92
2019
Q3 		– Sell
-8,200
Closed -$317K – 253
2019
Q2 		$317K Buy
8,200
+3,600
+78% +$983K 0.06% 103
2019
Q1 		$240K Sell
4,600
-5,800
-56% -$1.68M 0.03% 130
2018
Q4 		$55K Sell
10,400
-3,900
-27% -$1.07M 0.02% 205
2018
Q3 		$134K Buy
+14,300
New +$3.71M 0.04% 188

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

XR Securities's ELV Position: Q2 2023 in Review

XR Securities sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 4,497 shares — an estimated $2.07M sold.

XR Securities first reported a position in ELV in Q2 2018 and held it in 8 quarters. The position peaked at $4.4M in Q4 2019. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • XR Securities reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 4,497 Elevance Health shares in Q2 2023, an estimated $2.07M.
  • XR Securities first reported a position in Elevance Health in Q2 2018 and held it in 8 quarters.
  • XR Securities's Elevance Health position peaked at $4.4M in Q4 2019.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.